Spruce Biosciences Statistics
NASDAQ: SPRBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
38.00-2.49 (-6.15%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Spruce Biosciences by the numbers
Spruce Biosciences has a market capitalization of $109.2 million based on 2.87M shares outstanding. With trailing EPS of $-33.29, Spruce Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.8% below its 50-day average and 28.5% below its 200-day average.
Average daily trading volume is 89.33K shares, or about $3.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SPRB valuation vs. peer median
| Metric | SPRB | Peer median | Difference |
|---|---|---|---|
| Market cap | $109.21M | $109.40M | -0% |
| Avg. volume | 89.33K | 339.61K | -74% |
Peer median across 8 companies: BGM, MENS, IMUX, OKUR, AKBA, GNLX, FHTX, ADAG.
Valuation
- Market cap
- $109.21M
- Forward P/E
- 11.79
- EPS (TTM)
- $-33.29
- Shares outstanding
- 2.87M
Price and trading
- Previous close
- 40.49
- Open
- 39.97
- Day range
- 38.00 – 40.96
- 52-week range
- 38.00 – 111.00
- 52-week change
- -63.81%
- Beta
- —
- Volume
- 108.28K
- Average volume
- 89.33K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 109.21M
- Forward Pe
- 11.79
- Eps
- -33.29
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 111.00
- Week52 Low
- 38.00
- Avg Volume
- 89,335.00
- Shares Outstanding
- 2.87M
- Ma50
- 45.65
- Ma200
- 53.13
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -65.77%
- Pct From52w Low
- 0.00%